Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 41.75 USD -1.49% Market Closed
Market Cap: 6.6B USD
Have any thoughts about
Ionis Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

IONS Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast IONS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IONS is 58.18 USD with a low forecast of 37.37 USD and a high forecast of 87.15 USD.

Lowest
Price Target
37.37 USD
10% Downside
Average
Price Target
58.18 USD
39% Upside
Highest
Price Target
87.15 USD
109% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
KALV
Kalvista Pharmaceuticals Inc
97% Upside
214450
PharmaResearch Co Ltd
23% Downside
NGNE
Neurogene Inc
98% Upside
068270
Celltrion Inc
23% Upside
688293
Shanghai OPM Biosciences Co Ltd
3% Upside
UTHR
United Therapeutics Corp
32% Upside
300142
Walvax Biotechnology Co Ltd
21% Downside
BBIO
BridgeBio Pharma Inc
33% Upside

Revenue
Forecast

Revenue Estimate
Ionis Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 8%. The projected CAGR for the next 3 years is 19%.

8%
Past Growth
19%
Estimated Growth
Estimates Accuracy
10%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Ionis Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IONS's stock price target?
Price Target
58.18 USD

According to Wall Street analysts, the average 1-year price target for IONS is 58.18 USD with a low forecast of 37.37 USD and a high forecast of 87.15 USD.

What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 8%. The projected CAGR for the next 3 years is 19%.

Back to Top